
Frank Conlon, PhD
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded funding to Dr. Frank L. Conlon of the University of North Carolina to investigate the molecular basis of sex differences in congenital heart disease (CHD), the most common type of birth defect. The research focuses on DDX3X, an X-linked gene that Dr. Conlon’s team has identified as a critical regulator of heart development in females but not males, and which is linked to CHD in female patients. Using novel mouse models and cutting-edge techniques spanning genetics, proteomics, and RNA biology, the project aims to define how DDX3X controls the sex-specific translation of genes essential for cardiac function. These findings could advance understanding of why certain heart conditions affect the sexes differently and lay the groundwork for precision therapies tailored to patients with DDX3X-associated CHD.





